One of your browser extensions seems to be blocking the video player from loading. To watch this content, you may need to disable it on this site.
From the show
Reading time
1 min
France is Europe’s second-largest consumer of benzodiazepines – a class of sedatives that includes drugs like Valium and Xanax. Every year, nearly 10 million patients are prescribed these pills to treat anxiety and insomnia. While they are intended only for short-term use, treatments are often extended indefinitely, without proper supervision. Dependency sets in, affecting everyone from teenagers to elderly patients. FRANCE 24’s Olivia Bizot reports.
Europa Monitor is a seasoned News Editor with over a decade of experience in journalism. Known for his editorial expertise and commitment to accuracy, Europa Monitor leads teams to deliver high-quality news content.
